zoledronic acid has been researched along with Hemiplegia, Crossed in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Compston, J; Debiram, I; Loveridge, N; Poole, KE; Power, J; Reeve, J; Rose, C; Vedi, S; Warburton, EA | 1 |
| Loveridge, N; Poole, KE; Reeve, J; Rose, CM; Warburton, EA | 1 |
2 trial(s) available for zoledronic acid and Hemiplegia, Crossed
| Article | Year |
|---|---|
Bone structure and remodelling in stroke patients: early effects of zoledronate.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Female; Hemiplegia; Hip; Humans; Ilium; Imidazoles; Male; Microscopy, Fluorescence; Middle Aged; Osteoclasts; Osteoporosis; Stroke; Zoledronic Acid | 2009 |
A single infusion of zoledronate prevents bone loss after stroke.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Double-Blind Method; Female; Hemiplegia; Humans; Imidazoles; Male; Middle Aged; Stroke; Zoledronic Acid | 2007 |